Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Accenture
McKesson
Harvard Business School
UBS
Boehringer Ingelheim
McKinsey
US Department of Justice
Queensland Health
Cerilliant

Generated: August 17, 2017

DrugPatentWatch Database Preview

AMITRIPTYLINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Amitriptyline Hydrochloride, and when can generic versions of Amitriptyline Hydrochloride launch?

Amitriptyline Hydrochloride is a drug marketed by Par Pharm, Roxane, Purepac Pharm, Mylan, Teva, Watson Labs, Sun Pharm Inds Inc, Vangard, Vintage Pharms, Copley Pharm, Halsey, Mutual Pharm, Ani Pharms Inc, Ucb Inc, Lederle, Accord Hlthcare, West Ward, Superpharm, Sandoz, Am Therap, Usl Pharma, and Pliva. and is included in one hundred and seventeen NDAs.

The generic ingredient in AMITRIPTYLINE HYDROCHLORIDE is amitriptyline hydrochloride. There are thirteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the amitriptyline hydrochloride profile page.

Summary for Tradename: AMITRIPTYLINE HYDROCHLORIDE

Patents:0
Applicants:22
NDAs:117
Suppliers / Packagers: see list41
Bulk Api Vendors: see list57
Clinical Trials: see list2,327
Patent Applications: see list1,859
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:AMITRIPTYLINE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: AMITRIPTYLINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lederle
AMITRIPTYLINE HYDROCHLORIDE
amitriptyline hydrochloride
TABLET;ORAL086744-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva
AMITRIPTYLINE HYDROCHLORIDE
amitriptyline hydrochloride
TABLET;ORAL086859-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Halsey
AMITRIPTYLINE HYDROCHLORIDE
amitriptyline hydrochloride
TABLET;ORAL085922-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Vintage Pharms
AMITRIPTYLINE HYDROCHLORIDE
amitriptyline hydrochloride
TABLET;ORAL040218-005Sep 11, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe
Lederle
AMITRIPTYLINE HYDROCHLORIDE
amitriptyline hydrochloride
TABLET;ORAL086746-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Medtronic
Mallinckrodt
Cantor Fitzgerald
Cipla
Johnson and Johnson
Merck
Argus Health
Daiichi Sankyo
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot